Patented Medicine Prices Review Board Rules of Practice and Procedure (SOR/2012-247)
Full Document:
- HTMLFull Document: Patented Medicine Prices Review Board Rules of Practice and Procedure (Accessibility Buttons available) |
- XMLFull Document: Patented Medicine Prices Review Board Rules of Practice and Procedure [69 KB] |
- PDFFull Document: Patented Medicine Prices Review Board Rules of Practice and Procedure [212 KB]
Regulations are current to 2026-09-30 and last amended on 2021-06-30. Previous Versions
1 The definitions in this section apply in these Rules.
- Act
Act means the Patent Act. (Loi)
- Chairperson
Chairperson means the Chairperson of the Board designated under subsection 93(1) of the Act. (président)
- concerned minister
concerned minister means a federal Minister or a provincial minister referred to in subsection 86(2) of the Act, as the context requires. (ministre intéressé)
- counsel
counsel means a member of the bar of a province. (conseiller juridique)
- hearing
hearing includes a conference held under these Rules. (audience)
- party
party means
(a) a respondent;
(b) Board Staff;
(c) a concerned minister; or
(d) a person who has been granted leave to intervene under Rule 20. (partie)
- person
person includes an unincorporated organization or entity. (personne)
- respondent
respondent means a rights holder, or a former rights holder, against whom an order of the Board is proposed to be made under the Act. (intimé)
- Secretary
Secretary means the Director of Board Secretariat or anyone acting on her or his behalf. (secrétaire)
Page Details
- Date modified: